Regenerative medicine for spinal cord injury at subacute stage using human induced pluripotent stem cell-derived neural stem/progenitor cells

General Information

Clinical trials phase Not applicable
Start date (estimated) 2021-12-07
Clinical feature
Label Spinal cord injury
Link http://www.orpha.net/ORDO/Orphanet_90058

Administrative Information

ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCTa031190228
Other study identifiers
Name UMIN000035074
Description UMIN Clinical Trials Registry (UMIN-CTR)
Name jRCTa031190228
Description Japan Registry of Clinical Trials (jRCT)
Source weblink https://jrct.niph.go.jp/en-latest-detail/jRCTa031190228
Public contact
Email okanolab2020sci@gmail.com
Public email okanolab2020sci@gmail.com
First name Masaya
Last name Masaya
Phone +81 3-3353-1211
City Tokyo
Country
Japan
Address freetext 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 Japan
Sponsors Keio University

Cells

Which differentiated cell type is used
Label neural stem cell
Link http://purl.obolibrary.org/obo/CL_0000047
Description An undifferentiated neural cell that originates from the neuroectoderm and has the capacity both to perpetually self-renew without differentiating and to generate multiple central nervous system neuronal and glial cell types.

Recruitment

Recruitment Status Recruiting
Estimated number of participants 4